Neural Therapeutics Inc. (CSE:NURL)
Canada · Delayed Price · Currency is CAD 0.0300
0.00 (0.00%)
At close: Jul 18, 2025
Neural Therapeutics Company Description
Neural Therapeutics Inc., a drug discovery company, focuses on plant-based active substances.
It focuses on San Pedro, a cactus containing mescaline and delivers over-the-counter dietary supplements and psychedelic-based therapeutic medicines to treat serious mental ailments.
Neural Therapeutics Inc. was formerly known as Psychedelic Science Corp. and changed its name to Neural Therapeutics Inc. in November 2021.
The company was incorporated in 2020 and is headquartered in Toronto, Canada.
Neural Therapeutics Inc.
| Country | Canada |
| Founded | 2020 |
| Industry | Biological Products, Except Diagnostic Substances |
| CEO | Ian Campbell |
Contact Details
Address: 77 King Street West Toronto, Ontario M5K 1H1 Canada | |
| Website | neuraltherapeutics.ca |
Stock Details
| Ticker Symbol | NURL |
| Exchange | Canadian Securities Exchange |
| Fiscal Year | August - July |
| Reporting Currency | CAD |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Ian Campbell | Chief Executive Officer |
| Omar Gonzalez | Chief Financial Officer |